| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 22 |
| 1 | SPIRONOLACTONE | 17 |
| 2 | CYCLOPHOSPHAMIDE | 15 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| 5 | PACLITAXEL | 13 |
| 6 | GEMCITABINE HYDROCHLORIDE | 11 |
| 7 | POTASSIUM CHLORIDE | 11 |
| 8 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 11 |
| 9 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAMOXIFEN CITRATE | 9 | 0.0016 |
| 1 | VINORELBINE | 8 | 0.0011 |
| 2 | MITOMYCIN | 4 | 0.0011 |
| 3 | ALBUMIN HUMAN | 4 | 0.0008 |
| 4 | MEGESTROL ACETATE | 3 | 0.0008 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | ARGATROBAN | 1 | 0.0007 |
| 7 | HYOSCYAMINE SULFATE | 4 | 0.0004 |
| 8 | METHYLCELLULOSE | 1 | 0.0004 |
| 9 | ESOMEPRAZOLE SODIUM | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 27 |
| 1 | Aldosterone Antagonist [EPC] | 17 |
| 2 | Alkylating Drug [EPC] | 15 |
| 3 | Corticosteroid [EPC] | 15 |
| 4 | Microtubule Inhibitor [EPC] | 13 |
| 5 | Osmotic Laxative [EPC] | 13 |
| 6 | Potassium Salt [EPC] | 11 |
| 7 | Endothelin Receptor Antagonist [EPC] | 9 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bile Acid Sequestrant [EPC] | 4 | 0.0003 |
| 1 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 2 | Aluminum Complex [EPC] | 4 | 0.0002 |
| 3 | Estrogen Receptor Antagonist [EPC] | 6 | 0.0001 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 5 | Aldosterone Antagonist [EPC] | 17 | 0.0001 |
| 6 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Cardiac Glycoside [EPC] | 6 | 0.0001 |